Cboe Global Markets (CBOE) Earnings Date & Reports

Key Takeaways

• Record net revenue of $731.6 million — up 25% year-over-year — surpassed Wall Street consensus estimates by approximately $31 million.
• Adjusted diluted earnings per share (EPS) of $3.56 beat analyst expectations by roughly $0.20 and rose 45% from the prior-year period.
• Derivatives segment net revenue jumped 30%, fueled by record index options volumes and the continued dominance of zero-day-to-expiration (0DTE) trading in SPX options.
• Full-year organic net revenue growth guidance raised to the mid-to-high teens range, up from the prior low double-digit to mid-teens target.
• Adjusted operating EBITDA (earnings before interest, taxes, depreciation, and amortization) margin expanded to 72.2%, reflecting disciplined expense management alongside robust revenue growth.
• Shares rose modestly following the report, reflecting investor confidence in the company's strategic positioning and upgraded outlook.

Earnings Context and Why It Matters

Cboe Global Markets, the largest U.S. options exchange operator and home to the exclusive S&P 500 Index (SPX) options franchise, delivered its second consecutive quarter of record net revenue — reinforcing its position at the center of the retail and institutional options trading boom. The results arrive at a pivotal moment for the exchange industry, where surging trading volumes are colliding with questions around competitive threats from new products such as perpetual futures. Cboe's Q2 2026 performance provided a compelling counter-narrative: broad-based growth across all five business segments, expanding margins, and an upgraded full-year outlook. For investors, the report serves as a key barometer of how structural shifts in derivatives trading — including the accelerating adoption of short-dated options — translate into durable financial performance.

Reported Results

Cboe reported second-quarter 2026 net revenue of $731.6 million, a 25% increase from $587.3 million a year earlier and well above the consensus estimate of approximately $700 million. Adjusted diluted EPS came in at $3.56, up 45% year-over-year and comfortably ahead of the $3.36–$3.47 analyst consensus range. On a GAAP (Generally Accepted Accounting Principles) basis, diluted EPS was $3.35, up 50%.

The derivatives segment was the standout performer, generating net revenue of approximately $413 million — a 30% increase — driven by record index options average daily volume (ADV) of 6.2 million contracts, up 32% year-over-year. Total options ADV rose 26% to 21.9 million contracts. Zero-day-to-expiration (0DTE) options reached 65% of total SPX volume as of May 2026, up dramatically from 22% when Tuesday and Thursday expirations were introduced in 2022. The June 2026 repeal of the Pattern Day Trader rule further accelerated retail participation, with SPX 0DTE ADV climbing 48% and Mini-SPX 0DTE ADV doubling year-over-year.

Data Vantage, Cboe's non-transaction revenue business, posted 15% growth to approximately $178 million, supported by strong international demand for connectivity and market data. The Cash and Spot Markets segment grew 22%, benefiting from elevated volumes in both cash equities and foreign exchange. North American equities revenue rose 17%, while Europe and Asia-Pacific revenue increased 20% (18% in constant currency). Adjusted operating expenses rose just 2% to $216.7 million, demonstrating meaningful operating leverage.

Management raised its 2026 organic total net revenue growth target to the mid-to-high teens range and lifted the Data Vantage organic net revenue growth target to the low teens, while reaffirming adjusted operating expense guidance of $838 million to $853 million. Capital expenditure guidance was increased to $98–$108 million to support clearing infrastructure investments.

AI Screener

For investors seeking to identify earnings-driven opportunities like Cboe across thousands of stocks and ETFs, Tickeron's AI Screener offers a powerful, AI-driven solution. The AI Screener enables traders and investors to filter the market using customizable criteria such as industry classification, market capitalization, technical indicators, price patterns, volatility metrics, and proprietary AI-generated signals. Whether scanning for breakout candidates, trending stocks, or earnings-season setups, users can narrow their focus far more efficiently than with manual screening methods. The tool is designed to surface trade ideas and market opportunities grounded in data, helping both retail and professional investors stay ahead of shifting market conditions. Explore the AI Screener to see how AI-powered filtering can sharpen your market research.

Market Reaction and Investor Sentiment

Cboe shares moved modestly higher following the July 31, 2026 report, trading up roughly 0.6% to 2.6% in early action, depending on intraday timing. The relatively muted magnitude of the move — despite a sizable earnings beat — reflected the stock's strong year-to-date run of over 18%, as well as lingering market debate around competitive threats. Heading into the report, 17 analysts held a consensus neutral rating with a mean price target near $312, implying limited near-term upside from pre-earnings levels near $298–$308. The earnings beat and upgraded guidance provided a positive signal, particularly on margin execution and revenue diversification, though pricing pressure in multi-listed options and caution around perpetual futures competition remained topical concerns. Overall, investor sentiment appeared constructive, with the quality of broad-based growth outweighing isolated headwinds.

Forward Outlook and Key Factors to Monitor

Looking ahead, several factors will shape how investors assess Cboe's trajectory through the remainder of 2026 and into 2027. The company's upgraded organic net revenue growth guidance signals management confidence that elevated trading activity is not merely a temporary spike but reflects durable structural demand — particularly in short-dated options and retail engagement.

One of the most closely watched catalysts is Cboe's filing with the U.S. Securities and Exchange Commission (SEC) for company-specific KPI (Key Performance Indicator) event contracts covering 23 major U.S. companies. If approved, these products — which let investors trade on granular metrics such as a company's cloud revenue or data center performance — could launch as early as late September or early October 2026. Management has noted that no revenue from these contracts is embedded in current 2026 guidance, making them a potential upside driver.

Separately, the planned expansion of cash equities trading to a 23-by-5 schedule in December, the continued buildout of Cboe Clear U.S. clearing capabilities, and the launch of Cboe Predicts binary options all represent incremental growth initiatives. On the cost side, investors should monitor whether adjusted operating expenses stay within the $838–$853 million guided range, especially as the company invests in clearing infrastructure and return-to-office initiatives. The $650 million debt maturity in the first quarter of 2027 also warrants attention, as it may influence capital allocation decisions around share repurchases.

Broader industry dynamics — including regulatory developments around perpetual futures, potential shifts in corporate reporting frequency, and competitive moves by vertically integrated retail brokers — will also factor into how the market values Cboe's franchise. For now, the second-quarter results paint a picture of a company executing with speed and discipline, but maintaining growth at these levels will require continued product innovation and careful expense management.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations